- Report
- October 2024
- 185 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- September 2024
- 100 Pages
Global
From €5339EUR$5,950USD£4,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- March 2024
- 200 Pages
Global
From €3724EUR$4,150USD£3,205GBP
- Report
- December 2022
- 115 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- August 2022
- 120 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- December 2023
- 100 Pages
Africa
From €1795EUR$2,000USD£1,545GBP
- Report
- December 2023
- 180 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1346EUR$1,500USD£1,158GBP
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
Poland
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
United States
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
India
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
Germany
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
France
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 80 Pages
China
From €1346EUR$1,500USD£1,158GBP
- Report
- December 2023
- 255 Pages
Global
From €2243EUR$2,500USD£1,931GBP

Mefloquine is an antimalarial drug used to treat and prevent malaria. It is a member of the quinoline family of drugs and is used in combination with other antimalarial drugs. Mefloquine is also used to treat certain other infections, such as rickettsial infections, and is sometimes used as an adjunct to other treatments for malaria. Mefloquine is available in both oral and injectable forms.
Mefloquine is a widely used antimalarial drug, and is used in many countries around the world. It is generally well tolerated, although some people may experience side effects such as nausea, dizziness, and headaches. Mefloquine is also used to treat other infections, such as rickettsial infections, and is sometimes used as an adjunct to other treatments for malaria.
The mefloquine market is a competitive one, with many companies offering products. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, and Merck. Other companies in the market include Cipla, Lupin, and Sun Pharmaceuticals. Show Less Read more